The data for 2023 indicates significant variances in blood and blood forming organs medicine sales per capita across different countries. Iceland (73.8) leads, followed by Switzerland (58.4) and Sweden (58.2). Significant growth is observed in Mexico (8.45%), New Zealand (7.34%), and Iceland (7.17%). Conversely, Slovakia (-2.59%) shows a decline. Despite regional differences, the overall trend signifies increased spending, particularly in developed nations with robust healthcare systems.
Future Trends to Watch
Future trends in Global Blood and Blood Forming Organs Medicine Sales point towards increased spending driven by aging populations, advancements in medical treatments, and expanded healthcare access in emerging markets. Monitoring these trends will be crucial for anticipating market demands and pharmaceutical advancements.
Top countries in Blood and Blood Forming Organs Medicine Sales by Country
| # | 10 Countries | US Dollars Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Iceland | 73.8 | 2023 | +1.93% | +7.17% | View data |
| 2 | 2 Switzerland | 58.4 | 2023 | +7.16% | +4.66% | View data |
| 3 | 3 Sweden | 58.2 | 2023 | +2.83% | +2.08% | View data |
| 4 | 4 Austria | 56.6 | 2023 | +5.01% | +4.79% | View data |
| 5 | 5 South Korea | 47 | 2023 | +2.84% | +3.02% | View data |
| 6 | 6 Slovakia | 40.7 | 2023 | +3.04% | -2.59% | View data |
| 7 | 7 Estonia | 38.2 | 2023 | +4.95% | +3.74% | View data |
| 8 | 8 Ireland | 37.5 | 2023 | +3.88% | +4.56% | View data |
| 9 | 9 Canada | 33.1 | 2023 | +4.09% | +5.03% | View data |
| 10 | 10 United Kingdom | 30.1 | 2023 | +3.08% | +2.35% | View data |
